Crimean-Congo hemorrhagic fever (CCHF) is a highly contagious and often fatal tick-borne viral disease characterized by sudden fever, muscle pain, and bleeding, primarily prevalent across Africa, Asia, and Eastern Europe.
Hyperbaric oxygen therapy may potentially alleviate complications of Crimean-Congo hemorrhagic fever by promoting wound healing, reducing inflammation, and enhancing immune response in affected individuals.